Bradenton biopharmaceutical company acquires North Carolina business

  • Manatee-Sarasota
  • Share

A Bradenton-based biopharmaceutical company has acquired a North Carolina company focused on chemotherapy delivery systems. Continuity Biosciences did not disclose financial terms of its acquisition of Focal Medical.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • March 20, 2026
$10.25M Naples bayfront penthouse heads to auction
  • March 20, 2026
Bentley dealership opens in downtown Sarasota
  • March 19, 2026
Hoffmann Family sets opening date for Naples boutique
  • March 19, 2026
Luxury Naples community sells $50M in homes in first two months of 2026

Sponsored Content